PQ 550
550. Deputy Thomas Byrne asked the Minister for Health the reason for the delay in reimbursing osimertinib for patients suffering from non-small cell lung cancer; and the reason Ireland is not reimbursing the drug in line with other European countries. [4385/20]
Introduced
13 May 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
13 May 2020
Summary
550. Deputy Thomas Byrne asked the Minister for Health the reason for the delay in reimbursing osimertinib for patients suffering from non-small cell lung cancer; and the reason Ireland is not reimbursing the drug in line with other European countries. [4385/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Drugs Payment Scheme
Drugs Payment Scheme
xml · EN · 13 May 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-05-13/550/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-05-13/pq_550